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To the editor: 
 
The T2R38 bitter taste receptor on respiratory epithelia detects P. aeruginosa N-acyl-
L-homoserine lactones (AHLs). In vitro, T2R38 activation by AHLs initiates calcium-
mediated increases in nitric oxide production and ciliary beat frequency, dependent on 
polymorphisms in the TAS2R38 gene (1). In patients with chronic rhinosinusitis 
(CRS), TAS2R38 genotype is proposed to modify mucosal responses to P. aeruginosa 
(1).  
 
Polymorphisms in the TAS2R38 gene result in two high-frequency haplotypes, 
associated with taste perception of the bitter compound phenylthiocarbamide (2). The 
‘taster’ haplotype codes proline-alanine-valine (PAV); the ‘non-taster’ haplotype 
codes alanine-valine-isoleucine (AVI), at positions 49, 262, and 296 in the receptor 
protein. Responses to AHLs in vitro are greatest in PAV/PAV epithelial cells, and this 
genotype is reported to be protective against P. aeruginosa in the sinonasal airway 
(1).  
 
P. aeruginosa is the most frequently isolated respiratory pathogen in cystic fibrosis 
(CF), and chronic infection is associated with accelerated rates of disease progression. 
Determining the impact of TAS2R38 polymorphisms on P. aeruginosa infection in CF 
could have implications for patient risk stratification and, as naturally-occurring and 
synthetic agonists to T2R38 are already in clinical use (3), could identify promising 
therapeutic targets.  
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We characterized T2R38 localization in the CF airway and investigated the 
hypothesis that TAS2R38 polymorphisms would modify prevalence and impact of P. 
aeruginosa infection in CF. Some of the results of these studies have previously been 
reported as abstracts (4, 5). 
 
Methods 
Nasal and/or bronchial brushings were obtained from 4 CF children undergoing 
bronchoscopy and 4 healthy adult controls. T2R38 localization was evaluated by 
immunocytochemistry with antibodies to T2R38 and ciliary proteins, as described 
previously (6). Slides were imaged with a Zeiss LSM-510 confocal microscope and 
colocalization was quantified using the JACoP plug-in for ImageJ (7). 
 
DNA was extracted from blood from 271 subjects with CF aged >6yrs and subjected 
to PCR for the common TAS2R38 polymorphisms (rs713598, rs1726866, and 
rs10246939). P. aeruginosa infection status was categorised in patients with ≥3 
respiratory cultures during 2014, according to Leeds criteria (8), as chronic (>50% 
positive), intermittent (≤50% positive), free (previous P. aeruginosa but none for >12 
months), or never. Clinical data was obtained from each patient’s 2014 annual 
assessment. 
 
Cryo-preserved P. aeruginosa isolates from TAS2R38-genotyped patients (matched 
for age and FEV1) were revived in Luria-Bertani broth in triplicate and filter-
sterilized. Quantitative analysis of N-butanoyl-L-homoserine lactone (C4-HSL) and 
N-(3-oxododecanoyl)-L-homoserine lactone (3-oxo-C12-HSL) was performed by 
liquid chromatography with tandem mass spectrometry. Limits of detection and limits 
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of quantification were defined as signal:noise ratios of 3:1 and 10:1 respectively, as 
previously described (9). 
 
Power calculations predicted 250 patients would provide 80% power to detect a 
difference in chronic P. aeruginosa infection of ≥20% in PAV/PAV compared to 
other genotypes at α of 5%. Analysis of P. aeruginosa infection by TAS2R38 
genotype was by Chi-squared analysis and logistic regression. Graphpad Prism 7 and 
SPSS 23 were used and the null hypothesis was rejected at p<0.05. 
 
Ethical review committees (02-019 and 10/H0504/9) approved the protocol, and 
written consent was obtained from subjects or their parent/guardian.  
 
Results 
T2R38 immunostaining was present in all nasal (n=3) and bronchial (n=3) samples 
from CF patients and all nasal samples (n=4) from healthy controls. T2R38 stained 
proximally to acetylated α-tubulin (ciliary microtubules) and γ-tubulin (ciliary basal 
bodies), and colocalized with rootletin (ciliary rootlets) in CF and control cells 
(figure).  Thresholded Manders’ correlation coefficients (mean ± SD of 4 cells) for 
T2R38 and rootletin were 0.91 ± 0.07, 0.90 ± 0.08 and 0.90 ± 0.04 for control nasal, 
CF nasal, and CF bronchial cells respectively, indicating that ≥90% of green 
(rootletin) pixels were positive for red (T2R38).  
 
Of 271 CF patients, 225 had the common AVI/AVI (74), AVI/PAV (110) or 
PAV/PAV (41) genotypes and ≥3 respiratory cultures during 2014. Between 
TAS2R38 genotype groups there was no significant difference in median age, sex, or 
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proportion of p.Phe508del CFTR mutations. There was no association between 
TAS2R38 genotype and P. aeruginosa infection status (P=0.46) (table). In the logistic 
regression model with ‘intermittent and chronic’, and ‘never and free’ groups as 
dependent variables, and age, sex, CFTR genotype and TAS2R38 genotype as 
independent variables, only age was associated with intermittent or chronic P. 
aeruginosa infection (odds ratio 1.05, 95% CI 1.03-1.07). There was no association 
between TAS2R38 genotype and P. aeruginosa infection status when the PAV/PAV 
genotype was compared against AVI/AVI or AVI/PAV genotypes. 
 
Among patients with intermittent or chronic P. aeruginosa infection (n=141) there 
was no difference by TAS2R38 genotype in median percent-predicted FEV1 
(AVI/AVI 54.0%, AVI/PAV 62.0%, PAV/PAV 53.5%, p=0.3) or in the proportion of 
patients who isolated mucoid P. aeruginosa  (AVI/AVI 69%, AVI/PAV 60%, 
PAV/PAV 68%, p=0.5). In 18 P. aeruginosa isolates from TAS2R38-genotyped 
patients there was no difference by genotype in the proportion of isolates in which 
C4-HSL or 3-oxo-C12-HSL were below the limit of quantification (p=0.8).  
 
Discussion 
We have identified T2R38 in CF nasal and bronchial epithelium, where it localizes to 
the ciliary rootlet in the same distribution as in non-CF epithelia. Previous studies 
report T2R38 localization ranging from the ciliary tip (10) to below the ciliary base 
(1, 11). Our experiments demonstrate that in fresh, non-cultured cells, T2R38 
colocalizes with rootletin, a structural component of the ciliary rootlet, originating 
from the ciliary basal body and extending toward the nucleus (12).  
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In this study of 225 children and adults with CF we have found no association 
between TAS2R38 genotype and P. aeruginosa infection status, within the range of 
difference that our study was powered to detect. Our results show only age to be 
associated with intermittent or chronic infection, consistent with CF registry data (13). 
Among patients with intermittent or chronic infection, the lack of any difference in 
spirometry or prevalence of mucoid P. aeruginosa adds further evidence to the lack of 
a protective effect of the PAV/PAV genotype. Finally, in a small sample of clinical 
isolates we observed no relationship between TAS2R38 genotype and AHL profiles, 
suggesting that polymorphisms in this receptor are not exerting a selective pressure on 
P. aeruginosa in the CF lung.  
 
Our results indicate that TAS2R38-related differences in sinonasal immunity do not 
translate to clinically relevant changes in the CF airway, where mucociliary clearance 
is significantly impaired.  We suggest there to be no prognostic value of TAS2R38 
genotyping in patients with CF, nor do our findings indicate the T2R38 receptor to be 
a promising drug target in CF mucosal immunity. 
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FIGURE LEGEND 
Figure. Confocal microscopy images of nasal epithelial cells from a subject with CF. 
Cells were stained with antibodies to T2R38 (red), and acetylated α-tubulin (A) or 
rootletin (B) (both stained green). Nuclei were stained with 4’,6-diamidino-2-
phenylindole (DAPI) (blue). Colocalized antibodies appear yellow in the merged 
images. Epithelial cell morphology is shown by differential interference contrast 
(DIC) images. T2R38 stains proximally to acetylated α-tubulin (ciliary microtubules) 
and colocalizes with rootletin (ciliary rootlets). 
Antibodies used in these immunocytochemistry assays were: T2R38 (AB130503, 
Abcam, UK), acetylated α-tubulin (T6793, Sigma, UK), and rootletin (SC-374056, 
Santa Cruz Biotechnology, USA).   
 
 
 
Table. P. aeruginosa infection category by TAS2R38 genotype 
 AVI/AVI (n=74)  AVI/PAV (n=110)  PAV/PAV n=41 
Never, n(%) 
Free, n(%) 
Intermittent, n(%) 
Chronic, n(%) 
4 (5) 
21 (28) 
11 (15) 
38 (51) 
4 (4) 
36 (32) 
26 (24) 
44 (40) 
3 (7) 
16 (39) 
8 (20)  
14 (34) 
Definition of abbreviations: AVI = alanine-valine-isoleucine; PAV = proline-alanine-
valine. 
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To the editor: 
 
The T2R38 bitter taste receptor on respiratory epithelia detects P. aeruginosa N-acyl-
L-homoserine lactones (AHLs). In vitro, T2R38 activation by AHLs initiates calcium-
mediated increases in nitric oxide production and ciliary beat frequency, dependent on 
polymorphisms in the TAS2R38 gene (1). In patients with chronic rhinosinusitis 
(CRS), TAS2R38 genotype is proposed to modify mucosal responses to P. aeruginosa 
(1).  
 
Polymorphisms in the TAS2R38 gene result in two high-frequency haplotypes, 
associated with taste perception of the bitter compound phenylthiocarbamide (2). The 
‘taster’ haplotype codes proline-alanine-valine (PAV); the ‘non-taster’ haplotype 
codes alanine-valine-isoleucine (AVI), at positions 49, 262, and 296 in the receptor 
protein. Responses to AHLs in vitro are greatest in PAV/PAV epithelial cells, and this 
genotype is reported to be protective against P. aeruginosa in the sinonasal airway 
(1).  
 
P. aeruginosa is the most frequently isolated respiratory pathogen in cystic fibrosis 
(CF), and chronic infection is associated with accelerated rates of disease progression. 
Determining the impact of TAS2R38 polymorphisms on P. aeruginosa infection in CF 
could have implications for patient risk stratification and, as naturally-occurring and 
synthetic agonists to T2R38 are already in clinical use (3), could identify promising 
therapeutic targets.  
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We characterized T2R38 localization in the CF airway and investigated the 
hypothesis that TAS2R38 polymorphisms would modify prevalence and impact of P. 
aeruginosa infection in CF. Some of the results of these studies have previously been 
reported as abstracts (4, 5). 
 
Methods 
Nasal and/or bronchial brushings were obtained from 4 CF children undergoing 
bronchoscopy and 4 healthy adult controls. T2R38 localization was evaluated by 
immunocytochemistry with antibodies to T2R38 and ciliary proteins, as described 
previously (6). Slides were imaged with a Zeiss LSM-510 confocal microscope and 
colocalization was quantified using the JACoP plug-in for ImageJ (7). 
 
DNA was extracted from blood from 271 subjects with CF aged >6yrs and subjected 
to PCR for the common TAS2R38 polymorphisms (rs713598, rs1726866, and 
rs10246939). P. aeruginosa infection status was categorised in patients with ≥3 
respiratory cultures during 2014, according to Leeds criteria (8), as chronic (>50% 
positive), intermittent (≤50% positive), free (previous P. aeruginosa but none for >12 
months), or never. Clinical data was obtained from each patient’s 2014 annual 
assessment. 
 
Cryo-preserved P. aeruginosa isolates from TAS2R38-genotyped patients (matched 
for age and FEV1) were revived in Luria-Bertani broth in triplicate and filter-
sterilized. Quantitative analysis of N-butanoyl-L-homoserine lactone (C4-HSL) and 
N-(3-oxododecanoyl)-L-homoserine lactone (3-oxo-C12-HSL) was performed by 
liquid chromatography with tandem mass spectrometry. Limits of detection and limits 
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of quantification were defined as signal:noise ratios of 3:1 and 10:1 respectively, as 
previously described (9). 
 
Power calculations predicted 250 patients would provide 80% power to detect a 
difference in chronic P. aeruginosa infection of ≥20% in PAV/PAV compared to 
other genotypes at α of 5%. Analysis of P. aeruginosa infection by TAS2R38 
genotype was by Chi-squared analysis and logistic regression. Graphpad Prism 7 and 
SPSS 23 were used and the null hypothesis was rejected at p<0.05. 
 
Ethical review committees (02-019 and 10/H0504/9) approved the protocol, and 
written consent was obtained from subjects or their parent/guardian.  
 
Results 
T2R38 immunostaining was present in all nasal (n=3) and bronchial (n=3) samples 
from CF patients and all nasal samples (n=4) from healthy controls. T2R38 stained 
proximally to acetylated α-tubulin (ciliary microtubules) and γ-tubulin (ciliary basal 
bodies), and colocalized with rootletin (ciliary rootlets) in CF and control cells 
(figure).  Thresholded Manders’ correlation coefficients (mean ± SD of 4 cells) for 
T2R38 and rootletin were 0.91 ± 0.07, 0.90 ± 0.08 and 0.90 ± 0.04 for control nasal, 
CF nasal, and CF bronchial cells respectively, indicating that ≥90% of green 
(rootletin) pixels were positive for red (T2R38).  
 
Of 271 CF patients, 225 had the common AVI/AVI (74), AVI/PAV (110) or 
PAV/PAV (41) genotypes and ≥3 respiratory cultures during 2014. Between 
TAS2R38 genotype groups there was no significant difference in median age, sex, or 
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proportion of p.Phe508del CFTR mutations. There was no association between 
TAS2R38 genotype and P. aeruginosa infection status (P=0.46) (table). In the logistic 
regression model with ‘intermittent and chronic’, and ‘never and free’ groups as 
dependent variables, and age, sex, CFTR genotype and TAS2R38 genotype as 
independent variables, only age was associated with intermittent or chronic P. 
aeruginosa infection (odds ratio 1.05, 95% CI 1.03-1.07). There was no association 
between TAS2R38 genotype and P. aeruginosa infection status when the PAV/PAV 
genotype was compared against AVI/AVI or AVI/PAV genotypes. 
 
Among patients with intermittent or chronic P. aeruginosa infection (n=141) there 
was no difference by TAS2R38 genotype in median percent-predicted FEV1 
(AVI/AVI 54.0%, AVI/PAV 62.0%, PAV/PAV 53.5%, p=0.3) or in the proportion of 
patients who isolated mucoid P. aeruginosa  (AVI/AVI 69%, AVI/PAV 60%, 
PAV/PAV 68%, p=0.5). In 18 P. aeruginosa isolates from TAS2R38-genotyped 
patients there was no difference by genotype in the proportion of isolates in which 
C4-HSL or 3-oxo-C12-HSL were below the limit of quantification (p=0.8).  
 
Discussion 
We have identified T2R38 in CF nasal and bronchial epithelium, where it localizes to 
the ciliary rootlet in the same distribution as in non-CF epithelia. Previous studies 
report T2R38 localization ranging from the ciliary tip (10) to below the ciliary base 
(1, 11). Our experiments demonstrate that in fresh, non-cultured cells, T2R38 
colocalizes with rootletin, a structural component of the ciliary rootlet, originating 
from the ciliary basal body and extending toward the nucleus (12).  
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In this study of 225 children and adults with CF we have found no association 
between TAS2R38 genotype and P. aeruginosa infection status, within the range of 
difference that our study was powered to detect. Our results show only age to be 
associated with intermittent or chronic infection, consistent with CF registry data (13). 
Among patients with intermittent or chronic infection, the lack of any difference in 
spirometry or prevalence of mucoid P. aeruginosa adds further evidence to the lack of 
a protective effect of the PAV/PAV genotype. Finally, in a small sample of clinical 
isolates we observed no relationship between TAS2R38 genotype and AHL profiles, 
suggesting that polymorphisms in this receptor are not exerting a selective pressure on 
P. aeruginosa in the CF lung.  
 
Our results indicate that TAS2R38-related differences in sinonasal immunity do not 
translate to clinically relevant changes in the CF airway, where mucociliary clearance 
is significantly impaired.  We suggest there to be no prognostic value of TAS2R38 
genotyping in patients with CF, nor do our findings indicate the T2R38 receptor to be 
a promising drug target in CF mucosal immunity. 
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FIGURE LEGEND 
Figure. Confocal microscopy images of nasal epithelial cells from a subject with CF. 
Cells were stained with antibodies to T2R38 (red), and acetylated α-tubulin (A) or 
rootletin (B) (both stained green). Nuclei were stained with 4’,6-diamidino-2-
phenylindole (DAPI) (blue). Colocalized antibodies appear yellow in the merged 
images. Epithelial cell morphology is shown by differential interference contrast 
(DIC) images. T2R38 stains proximally to acetylated α-tubulin (ciliary microtubules) 
and colocalizes with rootletin (ciliary rootlets). 
Antibodies used in these immunocytochemistry assays were: T2R38 (AB130503, 
Abcam, UK), acetylated α-tubulin (T6793, Sigma, UK), and rootletin (SC-374056, 
Santa Cruz Biotechnology, USA).   
 
 
 
Table. P. aeruginosa infection category by TAS2R38 genotype 
 AVI/AVI (n=74)  AVI/PAV (n=110)  PAV/PAV n=41 
Never, n(%) 
Free, n(%) 
Intermittent, n(%) 
Chronic, n(%) 
4 (5) 
21 (28) 
11 (15) 
38 (51) 
4 (4) 
36 (32) 
26 (24) 
44 (40) 
3 (7) 
16 (39) 
8 (20)  
14 (34) 
Definition of abbreviations: AVI = alanine-valine-isoleucine; PAV = proline-alanine-
valine. 
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Table 2. Odds ratios for ‘intermittent or chronic’ P. aeruginosa infection by logistic 
regression 
 Univariate 
 Odds ratio Lower 95% 
CI 
Upper 95% 
CI 
Age 1.051 1.029 1.073 
Sex 
Male* 
Female 
 
1 
1.352 
 
 
0.785 
 
 
2.330 
CFTR 
F508/F508* 
F508/other 
Other/other 
 
1 
1.285 
1.465 
 
 
0.723 
0.521 
 
 
2.281 
4.121 
T2R38 
PAV/PAV* 
PAV/AVI 
AVI/AVI 
 
1 
1.511 
1.693 
 
 
0.731 
0.776 
 
 
3.125 
3.694 
• Baseline group for comparison of odds ratios by logistic regression. 
 
Page 22 of 22
